AsCNP/JSNP/JSCNP 2019

Presentation information

Print

[AsCNP] Symposium

AsCNP » [AsCNP] Symposium

[AsCNP_S40] Symposium-40
Noteworthy drug discovery/research and development - Aiming for innovation -

Sun. Oct 13, 2019 8:40 AM - 10:20 AM Room 1 (Main Hall)

Organizer / Chair: Tetsurou KIKUCHI (New Drug Research Division, Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd.), Co-chair: George KOOB (National Institute on Alcohol Abuse and Alcoholism, USA)

9:26 AM - 9:35 AM

[AsCNP-S40-6] BPN14770, an allosteric inhibitor of Phosphodiesterase 4D (PDE4D) developed for the treatment of Fragile X syndrome and other brain disorders such as Alzheimer’s disease

○Hiroko ONO1, Chong ZHANG2, Ying XU3, James M O’DONNELL2, 3, Hidekuni YAMAKAWA1, Naotaka HORIGUCHI1, Toshiyuki ASAKI1, Mark E GURNEY4 (1. Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., 2. Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 3. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 4. Tetra Discovery Partners Inc.)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.

Password